Prevalence of prediabetes, and diabetes in Chandigarh and Panchkula region based on glycated haemoglobin and Indian diabetes risk score
Open Access
- 11 November 2020
- journal article
- research article
- Published by Wiley in Endocrinology, Diabetes & Metabolism
- Vol. 4 (1)
Abstract
There is a rapid increase in the prevalence of diabetes in India. We wanted to review the status of prediabetes and diabetes in the combined population of Chandigarh and Panchkula region based on both Indian Diabetes Risk Score (IDRS) and Glycated Haemoglobin (HbA1c). A total of 1215 subjects were recruited during the screening process, out of which 444 i subjects have been analysed for the current study on the basis of high risk for IDRS (≥60) and their known diabetes status. This study included 431 subjects having high risk for IDRS (≥60) and 13 known subjects with diabetes (IDRS < 60) which were further analysed for biochemical and anthropometric parameters. The prevalence of diabetes was found to be 12.67% and prediabetes 11.69% in the combined population of Chandigarh and Panchkula. There was an increased level of fasting blood glucose (183.12 ± 68.61), postprandial blood glucose (262.57 ± 96.92), triglyceride (193.84 ± 119.88), very low‐density lipoprotein (VLDL) (34.87 ± 15.42) and High Density Lipoprotein(HDL) (4.61 ± 1.39) in the said diabetes population. Mean HDL was found to be decreased in subjects having diabetes. Glucose‐induced lipid intolerance study revealed significant alteration in triglyceride, HDL and VLDL. The study has revealed that high prevalence of diabetes in the sampled population when compared with the national average of 8.8%.Keywords
This publication has 27 references indexed in Scilit:
- Insulin-secreting adipose-derived mesenchymal stromal cells with bone marrow–derived hematopoietic stem cells from autologous and allogenic sources for type 1 diabetes mellitusCytotherapy, 2015
- HDL Cholesterol and Risk of Type 2 Diabetes: A Mendelian Randomization StudyDiabetes, 2015
- Prediabetes: a high-risk state for diabetes developmentThe Lancet, 2012
- HDL dysfunction in diabetes: causes and possible treatmentsExpert Review of Cardiovascular Therapy, 2012
- HbA1c 5·7–6·4% and impaired fasting plasma glucose for diagnosis of prediabetes and risk of progression to diabetes in Japan (TOPICS 3): a longitudinal cohort studyThe Lancet, 2011
- Prevalence and risk factors of diabetes in a community-based study in North India: The Chandigarh Urban Diabetes Study (CUDS)Diabetes & Metabolism, 2011
- The association between estimated average glucose levels and fasting plasma glucose levelsClinics, 2010
- A1C and Diabetes Diagnosis: The Rancho Bernardo StudyDiabetes Care, 2009
- Association between glycaemic control and serum lipids profile in type 2 diabetic patients: HbA1c predicts dyslipidaemiaClinical and Experimental Medicine, 2007
- Use of HbA1c in Predicting Progression to Diabetes in French Men and WomenDiabetes Care, 2006